This data visualisation provides specific country figures and policy recommendations about alcohol consumption in OECD countries. Please use the ‘+share/embed’ button to customize this tool for your country and language and to generate an embed code for your website.
Specific country notes have been prepared using data from the database OECD Health Statistics 2014, June 2014 version. The notes are available in PDF format.
Those in-depth studies of the health system of member countries focus on economic issues. They assess the performance of health systems in a comparative context, identify the main challenges faced by the country health system and put forward policy options to better meet them. Reviews are initiated at the request of the country to be examined and emphasis is placed on specific issues of key policy interest.
Across OECD countries some 83 million people suffer from diabetes. On current trends, that will rise to almost 100 million by 2030.
This report reviews the impact of pay increases on nurses’ labour market in four countries (UK, New Zealand, Finland and Czech Republic). Pay increases contributed to an increase in potential new entrants to nurse education, but the effect on nurses already in work is more difficult to assess.
The mortality amenable to health care is defined as a possible indicator to measure the health care systems performance in preventing premature deaths that can be avoided by appropriate health care intervention. This paper assesses the feasibility of using this indicator in OECD countries.
Too many workers leave the labour market permanently due to health problems, and yet too many people with a disabling condition are denied the opportunity to work. This third report in the OECD series Sickness, Disability and Work explores the possible factors behind this paradox. It looks specifically at the cases of Denmark, Finland, Ireland and the Netherlands, and highlights the roles of institutions and policies. A range
Summarises proceedings of a conference looking at examples of human genetic research databases, how they are established, how they are managed and governed, how they might be commercialised, and what the policy considerations might be.
This publication examines the innovation system in pharmaceutical biotechnology in eight OECD countries. Based on rich evidence, it draws policy recommendations to foster innovation in biopharmaceuticals advocating an integrated policy approach.
This book evaluates the performance of the Finnish health system in terms of quality of care, efficiency, fiscal sustainability and equity.